Cellebrite’s Reset: A New CEO, a Guide Down, and an AI Bet That Still Needs to Prove Out

A Planned Succession Becomes an Immediate Reset

Cellebrite's second-quarter report on August 13 was never going to be boring. The company announced a CEO change — Shiv Ramji, formerly President of Products and Technology, was named CEO, replacing Tom Hogan, who had led the company for just over a year. Chairman Adam Clammer framed it as a deliberate handoff:

When we brought Shiv on board, it was with the clear understanding that he was, for all intents and purposes, positioned to be Tom's successor. Shiv ramped much faster than we initially expected.

The timing, however, wasn't driven solely by succession planning. The quarter itself came up short. ARR grew 21% to $508 million, but that was below the low end of guidance. Revenue rose 16% to $131 million, and adjusted EBITDA landed at $31.8 million (24% margin). The miss was concentrated in a handful of large transactions that slipped past the quarter-end due to newly discovered procurement requirements tied to the company's foreign entity status, particularly in U.S. federal and European government cloud deals. “We did not deliver the ARR and revenue performance we expected in the second quarter.” — Shiven Ramji, Chief Executive Officer · 2026-08-13

New Products and a Cloud Inflection

Beneath the headline miss, there were encouraging signs for the platform strategy. The investigative life cycle was the organizing theme, with Genesis, a GenAI-powered investigative assistant, launched in June and already securing roughly $400,000 in ARR in its first weeks. Guardian Investigate and Advanced Unlocks also contributed meaningful net new ARR in their first full quarter. Defense and Intelligence ARR grew 25% year-over-year. Perhaps most tellingly, the company secured its first major FedRAMP deal for Guardian — a 7-figure order from a long-standing federal customer that highlighted the power of its cloud transition and AI pivot. CFO David Barter summed it up:

It's important to keep in mind that business model transitions are nonlinear. We have made great strides converting our customers to Insights. Equally, we are making great strides with regard to cloud and AI.

The cloud transition, however, is not without friction. As CRO Marcus Jewell explained on the call, European customers moving to cloud triggered unexpected legal reviews under new freedom-of-information rules, adding four to five weeks to deal cycles. “That was a surprise to both our customers and us, and we had quite a difficult process with legal review to get through that.” — Marcus Jewell, Chief Revenue Officer · 2026-08-13

These dynamics directly weighed on the full-year outlook. Management cut ARR guidance to $550–560 million (from a prior ~$565 million midpoint) and revenue to $555–561 million, while trimming EBITDA margin expectations to 28% (up from a prior ~27%? Actually they raised EBITDA target to $153-159M, which is higher than prior. Let's check: they said "We've raised our full year adjusted EBITDA targets to $153 million to $159 million, which represents a 28% margin." So they raised EBITDA margin? Possibly but on lower revenue. So it's a mixed guidance.

The company also acknowledged that Insights conversions, while on track in volume, are yielding less price uplift than expected.

A Pivot to Execution Discipline

The market's attention now shifts to whether the new leadership can deliver. In prior quarters, the narrative was about federal disruption and the promise of a reacceleration. As Tom Hogan said in May: “We do have confidence that that growth rate will accelerate in 2026.” — Thomas E. Hogan, Chief Executive Officer · 2025-11-12 That confidence has been tempered. The revised outlook assumes net new ARR in the second half is roughly flat versus 2025, reflecting prudence around deal timing and the impact of larger, more complex cloud deals.

Shiv Ramji's immediate priorities are clear: sales cycles and forecasting discipline. He stressed that “Pipeline is not performance.” — Shiven Ramji, Chief Executive Officer · 2026-08-13 The company is building a shared Cellebrite AI layer and extending Genesis into high-security environments, including an air-gapped offering with an anchor customer. Whether this translates into durable growth will depend on execution — and on how quickly the administrative logjams that plagued Q2 can be resolved.

For investors, the quarter is a reminder that a pivot to cloud and AI in the public sector is a multi-year effort, not a one-quarter event. The company's platform strategy is showing real traction, but the near-term volatility in ARR and revenue is a cost of that transition. The new CEO brings a product-centric lens, but the proof will be in the numbers.